A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors

Clinical trial NCT00634231 · COMPLETED

Trial details

NCT number: NCT00634231
Sponsor: Candel Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma Recurrent Ependymoma

Start date: 2010-10-01
Primary completion: 2015-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.